Geron | GERN - Equity Capital And Reserves

Stock Price
1.77
Daily Change
-0.19 -9.49%
Monthly
28.83%
Yearly
9.63%
Q1 Forecast
1.82

Geron reported $248.71M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Amgen USD 8.66B 961M Dec/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Cassava Sciences USD 81.57M 6.4M Sep/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Esperion Therapeutics USD -451.36M 17.85M Sep/2025
Exelixis USD 2.16B 619K Dec/2025
Genmab DKK 5.3B 6M Jun/2025
Geron USD 248.71M 10.82M Sep/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
MacroGenics USD 67M 20.38M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Novavax USD -156.67M 194.3M Sep/2025